Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wall

Showing results (571-580 of 586) with videos related to

Pageof 59
Sort By:
Molecular & Cellular Proteomics : MCP|February 14, 2016
Bacterial Interactomes: Interacting Protein Partners Share Similar Function and Are Validated in Independent Assays More Frequently Than Previously ReportedMaxim Shatsky, Simon Allen, Barbara L Gold, et al.
Journal of Medicinal Chemistry|June 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity <i>In Vivo</i>Christopher P Tinworth, Justyna Wojno-Picon, Michael Adam, et al.
The British Journal of Dermatology|August 25, 2019
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczemaA L Bosma, P I Spuls, I Garcia-Doval, et al.
Nature Ecology & Evolution|March 25, 2022
Genomic signatures of high-altitude adaptation and chromosomal polymorphism in geladasKenneth L Chiou, Mareike C Janiak, India A Schneider-Crease, et al.
Journal of Medicinal Chemistry|November 15, 2022
Identification and Optimization of a Ligand-Efficient Benzoazepinone Bromodomain and Extra Terminal (BET) Family Acetyl-Lysine Mimetic into the Oral Candidate Quality Molecule I-BET432Philip G Humphreys, Niall A Anderson, Paul Bamborough, et al.
Chemosphere|May 18, 2020
Characterization of subsurface media from locations up- and down-gradient of a uranium-contaminated aquiferJi-Won Moon, Charles J Paradis, Dominique C Joyner, et al.
Journal of Medicinal Chemistry|April 13, 2026
Automated Molecular Design in BRADSHAW, Applied to the Optimization of ERAP1 InhibitorsRobert P Law, Ian D Wall, Richard Lonsdale, et al.
Nature Biotechnology|April 13, 2004
The genome sequence of the anaerobic, sulfate-reducing bacterium Desulfovibrio vulgaris HildenboroughJohn F Heidelberg, Rekha Seshadri, Shelley A Haveman, et al.
Journal of Medicinal Chemistry|January 7, 2020
Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment ScreeningChristopher R Wellaway, Dominique Amans, Paul Bamborough, et al.
Journal of Medicinal Chemistry|June 12, 2024
Structure- and Property-Based Optimization of Efficient Pan-Bromodomain and Extra Terminal Inhibitors to Identify Oral and Intravenous Candidate I-BET787David J Hirst, Paul Bamborough, Niam Al-Mahdi, et al.
Pageof 59

Showing results (571-580 of 586) with videos related to

Sort By:
Pageof 59
Molecular & Cellular Proteomics : MCP|February 14, 2016
Bacterial Interactomes: Interacting Protein Partners Share Similar Function and Are Validated in Independent Assays More Frequently Than Previously ReportedMaxim Shatsky, Simon Allen, Barbara L Gold, et al.
Journal of Medicinal Chemistry|June 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity <i>In Vivo</i>Christopher P Tinworth, Justyna Wojno-Picon, Michael Adam, et al.
The British Journal of Dermatology|August 25, 2019
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczemaA L Bosma, P I Spuls, I Garcia-Doval, et al.
Nature Ecology & Evolution|March 25, 2022
Genomic signatures of high-altitude adaptation and chromosomal polymorphism in geladasKenneth L Chiou, Mareike C Janiak, India A Schneider-Crease, et al.
Journal of Medicinal Chemistry|November 15, 2022
Identification and Optimization of a Ligand-Efficient Benzoazepinone Bromodomain and Extra Terminal (BET) Family Acetyl-Lysine Mimetic into the Oral Candidate Quality Molecule I-BET432Philip G Humphreys, Niall A Anderson, Paul Bamborough, et al.
Chemosphere|May 18, 2020
Characterization of subsurface media from locations up- and down-gradient of a uranium-contaminated aquiferJi-Won Moon, Charles J Paradis, Dominique C Joyner, et al.
Journal of Medicinal Chemistry|April 13, 2026
Automated Molecular Design in BRADSHAW, Applied to the Optimization of ERAP1 InhibitorsRobert P Law, Ian D Wall, Richard Lonsdale, et al.
Nature Biotechnology|April 13, 2004
The genome sequence of the anaerobic, sulfate-reducing bacterium Desulfovibrio vulgaris HildenboroughJohn F Heidelberg, Rekha Seshadri, Shelley A Haveman, et al.
Journal of Medicinal Chemistry|January 7, 2020
Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment ScreeningChristopher R Wellaway, Dominique Amans, Paul Bamborough, et al.
Journal of Medicinal Chemistry|June 12, 2024
Structure- and Property-Based Optimization of Efficient Pan-Bromodomain and Extra Terminal Inhibitors to Identify Oral and Intravenous Candidate I-BET787David J Hirst, Paul Bamborough, Niam Al-Mahdi, et al.
Pageof 59